Day One Biopharmaceuticals Acquired by Servier | Healthcare M&A Deal

Servier has completed the acquisition of Day One Biopharmaceuticals, a medical devices business in the United States, for $2.5 billion. Servier acquires Day One Biopharmaceuticals to expand healthcare capabilities tied to medical devices and biopharmaceutical innovation. Day One Biopharmaceuticals acquisition supports product development and commercialization efforts across healthcare M&A priorities. The Servier acquisitions are structured as a platform acquisition and are categorized as a strategic acquisition by a strategic buyer, with deal size over $100M and a closed status.